Approximately 30 % of the variation in mortality rates from prostate cancer can be attributed to the accessibility of the PSA test [5], but AA men are less likely to have screened with a PSA test compared to non-Hispanic White men nationally [6] and in Oklahoma [7]. This evidence concerns the gene KLK3 and Familial prostate cancer.